MC
ALXN

Machina Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Machina Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,655
Closed -$395K – 327
2019
Q4 		$395K Sell
3,655
-5,705
-61% -$610K 0.16% 227
2019
Q3 		$917K Buy
9,360
+9,304
+16,614% +$1.05M 0.42% 74
2019
Q2 		$7K Buy
+56
New +$7.22K ﹤0.01% 472
2019
Q1 		– Sell
-3,261
Closed -$317K – 566
2018
Q4 		$317K Buy
+3,261
New +$385K 0.21% 173

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Machina Capital's ALXN Position: Q1 2020 in Review

Machina Capital sold out of Alexion Pharmaceuticals (ALXN) in Q1 2020, closing a stake of 3,655 shares — an estimated $395K sold.

Machina Capital first reported a position in ALXN in Q4 2018 and held it in 4 quarters. The position peaked at $917K in Q3 2019. 654 funds tracked by Wall St. Rank hold ALXN as of Q1 2020.

  • Machina Capital reported no remaining Alexion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Machina Capital sold 3,655 Alexion Pharmaceuticals shares in Q1 2020, an estimated $395K.
  • Machina Capital first reported a position in Alexion Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Machina Capital's Alexion Pharmaceuticals position peaked at $917K in Q3 2019.
  • 654 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2020.

Based on Machina Capital's 13F filing for Q1 2020.